Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Septicemia | Research

Prognostic impacts of repeated sepsis in intensive care unit on autoimmune disease patients: a retrospective cohort study

Authors: Jinming Yang, Jie Chen, Min Zhang, Qingsa Zhou, Bing Yan

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Background

Autoimmune diseases (ADs) may be complicated by sepsis when intensive care unit (ICU) admission. But repeated sepsis among AD patients has not been studied yet. The aim of this study is to investigate the impact of repeated in-ICU sepsis on the 1-year overall-cause mortality, septic shock and in-ICU death of AD patients.

Methods

Data of AD patients with sepsis retrieved from Medical Information Mart for Intensive Care IV (MIMIC-IV) database were divided into the single group and the repeated group according to the frequency of in-ICU sepsis. Propensity score matching was used to balance inter-group bias. Cox proportional hazard regression and sensitivity analysis were utilized to assess the variables on mortality.

Results

The incidence of repeated in-ICU sepsis in baseline was 19.8%. The repeated in-ICU sepsis was a risk factor for 1-year overall-cause mortality among AD patients (adjusted hazard ratio [HR] = 1.50, 95% CI: 1.16–1.93, P = 0.002), with robust adjusted HRs by the adjustment for confounders in the sensitivity analysis (all P < 0.01). Maximum Sequential Organ Failure Assessment (Max SOFA), Charlson comorbidity index (CCI) and Simplified Acute Physiology Score-II (SAPS-II) were risk factors for 1-year overall-cause mortality among AD with repeated sepsis (Max SOFA: HR = 1.09, P = 0.002; CCI: HR = 1.08, P = 0.039; SAPS-II: HR = 1.03, P < 0.001).

Conclusions

Compared to single hit, repeated in-ICU sepsis was independently related to a higher risk of 1-year overall-cause mortality among AD patients. Assessment tools (Higher SOFA, CCI and SAPS-II scores) were closely linked to poor prognosis of AD with repeated sepsis and helped to reflect ill physical conditions for the patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Singh JA, Cleveland JD. Hospitalized infections in Lupus: a nationwide study of types of infections, Time Trends, Health Care utilization, and In-Hospital mortality. Arthritis & Rheumatology. 2021;73(4):617–30.CrossRef Singh JA, Cleveland JD. Hospitalized infections in Lupus: a nationwide study of types of infections, Time Trends, Health Care utilization, and In-Hospital mortality. Arthritis & Rheumatology. 2021;73(4):617–30.CrossRef
2.
go back to reference van der Poll T, Shankar-Hari M, Wiersinga WJ. The immunology of sepsis. Immunity. 2021;54(11):2450–64.CrossRefPubMed van der Poll T, Shankar-Hari M, Wiersinga WJ. The immunology of sepsis. Immunity. 2021;54(11):2450–64.CrossRefPubMed
3.
go back to reference Angus DC, van der Poll T. Severe Sepsis and septic shock. New Engl J Med 2013, 369(9):840–51. Angus DC, van der Poll T. Severe Sepsis and septic shock. New Engl J Med 2013, 369(9):840–51.
4.
go back to reference Jinno S, Lu N, Jafarzadeh SR, Dubreuil M. Trends in Hospitalizations for Serious infections in patients with rheumatoid arthritis in the US between 1993 and 2013. Arthritis Care Res. 2018;70(4):652–8.CrossRef Jinno S, Lu N, Jafarzadeh SR, Dubreuil M. Trends in Hospitalizations for Serious infections in patients with rheumatoid arthritis in the US between 1993 and 2013. Arthritis Care Res. 2018;70(4):652–8.CrossRef
5.
go back to reference Krasselt M, Baerwald C, Petros S, Seifert O. Sepsis mortality is high in patients with connective tissue diseases admitted to the Intensive Care Unit (ICU). J Intensive Care Med. 2022;37(3):401–7.CrossRefPubMed Krasselt M, Baerwald C, Petros S, Seifert O. Sepsis mortality is high in patients with connective tissue diseases admitted to the Intensive Care Unit (ICU). J Intensive Care Med. 2022;37(3):401–7.CrossRefPubMed
7.
go back to reference van Vught LA, Wiewel MA, Hoogendijk AJ, Frencken JF, Scicluna BP, Klouwenberg PMCK, Zwinderman AH, Lutter R, Horn J, Schultz MJ, et al. The Host Response in patients with Sepsis developing Intensive Care unit–acquired secondary infections. Am J Respir Crit Care Med. 2017;196(4):458–70.CrossRefPubMed van Vught LA, Wiewel MA, Hoogendijk AJ, Frencken JF, Scicluna BP, Klouwenberg PMCK, Zwinderman AH, Lutter R, Horn J, Schultz MJ, et al. The Host Response in patients with Sepsis developing Intensive Care unit–acquired secondary infections. Am J Respir Crit Care Med. 2017;196(4):458–70.CrossRefPubMed
8.
go back to reference Cui Z, Wang L, Li H, Feng M. Study on immune status alterations in patients with sepsis. Int Immunopharmacol. 2023;118:110048.CrossRefPubMed Cui Z, Wang L, Li H, Feng M. Study on immune status alterations in patients with sepsis. Int Immunopharmacol. 2023;118:110048.CrossRefPubMed
9.
go back to reference Pandolfi F, Brun-Buisson C, Guillemot D, Watier L. One-year hospital readmission for recurrent sepsis: associated risk factors and impact on 1-year mortality-a French nationwide study. Crit Care. 2022;26(1):371–1.CrossRefPubMedPubMedCentral Pandolfi F, Brun-Buisson C, Guillemot D, Watier L. One-year hospital readmission for recurrent sepsis: associated risk factors and impact on 1-year mortality-a French nationwide study. Crit Care. 2022;26(1):371–1.CrossRefPubMedPubMedCentral
10.
go back to reference DeMerle KM, Royer SC, Mikkelsen ME, Prescott HC. Readmissions for recurrent Sepsis: New or relapsed infection?*. Crit Care Med 2017, 45(10). DeMerle KM, Royer SC, Mikkelsen ME, Prescott HC. Readmissions for recurrent Sepsis: New or relapsed infection?*. Crit Care Med 2017, 45(10).
11.
go back to reference Goldberger AL, Amaral LA, Glass L, Hausdorff JM, Ivanov PC, Mark RG, Mietus JE, Moody GB, Peng CK, Stanley HE. PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals. Circulation. 2000;101(23):E215–220.CrossRefPubMed Goldberger AL, Amaral LA, Glass L, Hausdorff JM, Ivanov PC, Mark RG, Mietus JE, Moody GB, Peng CK, Stanley HE. PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals. Circulation. 2000;101(23):E215–220.CrossRefPubMed
12.
go back to reference Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707–10.CrossRefPubMed Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707–10.CrossRefPubMed
13.
go back to reference Charlson ME, Carrozzino D, Guidi J, Patierno C. Charlson Comorbidity Index: a critical review of Clinimetric Properties. Psychother Psychosom. 2022;91(1):8–35.CrossRefPubMed Charlson ME, Carrozzino D, Guidi J, Patierno C. Charlson Comorbidity Index: a critical review of Clinimetric Properties. Psychother Psychosom. 2022;91(1):8–35.CrossRefPubMed
14.
go back to reference Le Gall J-R, Lemeshow S, Saulnier F. A New Simplified Acute Physiology score (SAPS II) based on a European/North American Multicenter Study. JAMA. 1993;270(24):2957–63.CrossRefPubMed Le Gall J-R, Lemeshow S, Saulnier F. A New Simplified Acute Physiology score (SAPS II) based on a European/North American Multicenter Study. JAMA. 1993;270(24):2957–63.CrossRefPubMed
15.
go back to reference Mageau A, Sacré K, Perozziello A, Ruckly S, Dupuis C, Bouadma L, Papo T, Timsit JF. Septic shock among patients with systemic lupus erythematosus: short and long-term outcome. Analysis of a French nationwide database. J Infect. 2019;78(6):432–8.CrossRefPubMed Mageau A, Sacré K, Perozziello A, Ruckly S, Dupuis C, Bouadma L, Papo T, Timsit JF. Septic shock among patients with systemic lupus erythematosus: short and long-term outcome. Analysis of a French nationwide database. J Infect. 2019;78(6):432–8.CrossRefPubMed
16.
go back to reference Bernal-Macías S, Reyes-Beltrán B, Molano-González N, Augusto Vega D, Bichernall C, Díaz LA, Rojas-Villarraga A, Anaya JM. Outcome of patients with autoimmune diseases in the intensive care unit: a mixed cluster analysis. Lupus Sci Med. 2015;2(1):e000122–2.CrossRefPubMedPubMedCentral Bernal-Macías S, Reyes-Beltrán B, Molano-González N, Augusto Vega D, Bichernall C, Díaz LA, Rojas-Villarraga A, Anaya JM. Outcome of patients with autoimmune diseases in the intensive care unit: a mixed cluster analysis. Lupus Sci Med. 2015;2(1):e000122–2.CrossRefPubMedPubMedCentral
17.
18.
go back to reference Goodwin AJ, Rice DA, Simpson KN, Ford DW. Frequency, cost, and risk factors of readmissions among severe sepsis survivors. Crit Care Med. 2015;43(4):738–46.CrossRefPubMedPubMedCentral Goodwin AJ, Rice DA, Simpson KN, Ford DW. Frequency, cost, and risk factors of readmissions among severe sepsis survivors. Crit Care Med. 2015;43(4):738–46.CrossRefPubMedPubMedCentral
19.
go back to reference Fry CH, Fluck D, Han TS. Frequent identical admission-readmission episodes are associated with increased mortality. Clin Med (Lond). 2021;21(4):e351–6.CrossRefPubMed Fry CH, Fluck D, Han TS. Frequent identical admission-readmission episodes are associated with increased mortality. Clin Med (Lond). 2021;21(4):e351–6.CrossRefPubMed
20.
go back to reference Oud L. Epidemiology and outcomes of sepsis among hospitalizations with systemic lupus erythematosus admitted to the ICU: a population-based cohort study. J Intensive Care. 2020;8:3–3.CrossRefPubMedPubMedCentral Oud L. Epidemiology and outcomes of sepsis among hospitalizations with systemic lupus erythematosus admitted to the ICU: a population-based cohort study. J Intensive Care. 2020;8:3–3.CrossRefPubMedPubMedCentral
21.
go back to reference Ammer-Herrmenau C, Kulkarni U, Andreas N, Ungelenk M, Ravens S, Hübner C, Kather A, Kurth I, Bauer M, Kamradt T. Sepsis induces long-lasting impairments in CD4 + T-cell responses despite rapid numerical recovery of T-lymphocyte populations. PLoS ONE. 2019;14(2):e0211716.CrossRefPubMedPubMedCentral Ammer-Herrmenau C, Kulkarni U, Andreas N, Ungelenk M, Ravens S, Hübner C, Kather A, Kurth I, Bauer M, Kamradt T. Sepsis induces long-lasting impairments in CD4 + T-cell responses despite rapid numerical recovery of T-lymphocyte populations. PLoS ONE. 2019;14(2):e0211716.CrossRefPubMedPubMedCentral
22.
go back to reference He W, Xiao K, Xu J, Guan W, Xie S, Wang K, Yan P, Fang M, Xie L. Recurrent Sepsis exacerbates CD4(+) T cell exhaustion and decreases antiviral Immune responses. Front Immunol. 2021;12:627435.CrossRefPubMedPubMedCentral He W, Xiao K, Xu J, Guan W, Xie S, Wang K, Yan P, Fang M, Xie L. Recurrent Sepsis exacerbates CD4(+) T cell exhaustion and decreases antiviral Immune responses. Front Immunol. 2021;12:627435.CrossRefPubMedPubMedCentral
23.
go back to reference Duong S, Condotta SA, Rai D, Martin MD, Griffith TS, Badovinac VP. Polymicrobial sepsis alters antigen-dependent and -independent memory CD8 T cell functions. J Immunol (Baltimore Md: 1950). 2014;192(8):3618–25.CrossRef Duong S, Condotta SA, Rai D, Martin MD, Griffith TS, Badovinac VP. Polymicrobial sepsis alters antigen-dependent and -independent memory CD8 T cell functions. J Immunol (Baltimore Md: 1950). 2014;192(8):3618–25.CrossRef
24.
go back to reference Cavassani KA, Carson WFt, Moreira AP, Wen H, Schaller MA, Ishii M, Lindell DM, Dou Y, Lukacs NW, Keshamouni VG, et al. The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth. Blood. 2010;115(22):4403–11.CrossRefPubMedPubMedCentral Cavassani KA, Carson WFt, Moreira AP, Wen H, Schaller MA, Ishii M, Lindell DM, Dou Y, Lukacs NW, Keshamouni VG, et al. The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth. Blood. 2010;115(22):4403–11.CrossRefPubMedPubMedCentral
25.
go back to reference Mathias B, Delmas AL, Ozrazgat-Baslanti T, Vanzant EL, Szpila BE, Mohr AM, Moore FA, Brakenridge SC, Brumback BA, Moldawer LL et al. Human myeloid-derived suppressor cells are Associated with Chronic Immune suppression after severe Sepsis/Septic shock. Annals of Surgery 2017, 265(4):827–34. Mathias B, Delmas AL, Ozrazgat-Baslanti T, Vanzant EL, Szpila BE, Mohr AM, Moore FA, Brakenridge SC, Brumback BA, Moldawer LL et al. Human myeloid-derived suppressor cells are Associated with Chronic Immune suppression after severe Sepsis/Septic shock. Annals of Surgery 2017, 265(4):827–34.
26.
go back to reference Yao RQ, Zhao PY, Li ZX, Liu YY, Zheng LY, Duan Y, Wang L, Yang RL, Kang HJ, Hao JW, et al. Single-cell transcriptome profiling of sepsis identifies HLA-DR(low)S100A(high) monocytes with immunosuppressive function. Military Med Res. 2023;10(1):27.CrossRef Yao RQ, Zhao PY, Li ZX, Liu YY, Zheng LY, Duan Y, Wang L, Yang RL, Kang HJ, Hao JW, et al. Single-cell transcriptome profiling of sepsis identifies HLA-DR(low)S100A(high) monocytes with immunosuppressive function. Military Med Res. 2023;10(1):27.CrossRef
27.
go back to reference Liu D, Huang SY, Sun JH, Zhang HC, Cai QL, Gao C, Li L, Cao J, Xu F, Zhou Y, et al. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Military Med Res. 2022;9(1):56.CrossRef Liu D, Huang SY, Sun JH, Zhang HC, Cai QL, Gao C, Li L, Cao J, Xu F, Zhou Y, et al. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Military Med Res. 2022;9(1):56.CrossRef
28.
go back to reference He Y, Xu J, Shang X, Fang X, Gao C, Sun D, Yao L, Zhou T, Pan S, Zou X et al. Clinical characteristics and risk factors associated with ICU-acquired infections in sepsis: a retrospective cohort study. Front Cell Infect Microbiol 2022, 12. He Y, Xu J, Shang X, Fang X, Gao C, Sun D, Yao L, Zhou T, Pan S, Zou X et al. Clinical characteristics and risk factors associated with ICU-acquired infections in sepsis: a retrospective cohort study. Front Cell Infect Microbiol 2022, 12.
29.
go back to reference Quintero OL, Rojas-Villarraga A, Mantilla RD, Anaya JM. Autoimmune diseases in the intensive care unit. An update. Autoimmun Rev. 2013;12(3):380–95.CrossRefPubMed Quintero OL, Rojas-Villarraga A, Mantilla RD, Anaya JM. Autoimmune diseases in the intensive care unit. An update. Autoimmun Rev. 2013;12(3):380–95.CrossRefPubMed
30.
go back to reference Kim S-K, Choe J-Y, Lee S-S. Charlson Comorbidity Index is related to organ damage in systemic Lupus Erythematosus: data from KORean lupus Network (KORNET) Registry. J Rheumatol 2017, 44(4):452–2. Kim S-K, Choe J-Y, Lee S-S. Charlson Comorbidity Index is related to organ damage in systemic Lupus Erythematosus: data from KORean lupus Network (KORNET) Registry. J Rheumatol 2017, 44(4):452–2.
31.
go back to reference Krasselt M, Baerwald C, Petros S, Seifert O. Mortality of Sepsis in patients with rheumatoid arthritis: a single-center retrospective analysis and comparison with a Control Group. J Intensive Care Med. 2021;36(7):766–74.CrossRefPubMed Krasselt M, Baerwald C, Petros S, Seifert O. Mortality of Sepsis in patients with rheumatoid arthritis: a single-center retrospective analysis and comparison with a Control Group. J Intensive Care Med. 2021;36(7):766–74.CrossRefPubMed
32.
go back to reference Kelm DJ, Perrin JT, Cartin-Ceba R, Gajic O, Schenck L, Kennedy CC. Fluid overload in patients with severe sepsis and septic shock treated with early goal-directed therapy is associated with increased acute need for fluid-related medical interventions and hospital death. Shock (Augusta Ga). 2015;43(1):68–73.CrossRefPubMed Kelm DJ, Perrin JT, Cartin-Ceba R, Gajic O, Schenck L, Kennedy CC. Fluid overload in patients with severe sepsis and septic shock treated with early goal-directed therapy is associated with increased acute need for fluid-related medical interventions and hospital death. Shock (Augusta Ga). 2015;43(1):68–73.CrossRefPubMed
33.
go back to reference Chandra J, de la Armengol MA, Lee G, Lee A, Thoral P, Elbers P, Lee HC, Munger JS, Celi LA, Kaufman DA. A novel vascular Leak Index identifies sepsis patients with a higher risk for in-hospital death and fluid accumulation. Crit Care. 2022;26(1):103.CrossRefPubMedPubMedCentral Chandra J, de la Armengol MA, Lee G, Lee A, Thoral P, Elbers P, Lee HC, Munger JS, Celi LA, Kaufman DA. A novel vascular Leak Index identifies sepsis patients with a higher risk for in-hospital death and fluid accumulation. Crit Care. 2022;26(1):103.CrossRefPubMedPubMedCentral
34.
go back to reference Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013;13(3):260–8.CrossRefPubMedPubMedCentral Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013;13(3):260–8.CrossRefPubMedPubMedCentral
35.
go back to reference Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–96.CrossRefPubMed Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–96.CrossRefPubMed
36.
go back to reference Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet (London England). 2018;392(10141):75–87.CrossRefPubMed Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet (London England). 2018;392(10141):75–87.CrossRefPubMed
37.
go back to reference van der Slikke EC, An AY, Hancock REW, Bouma HR. Exploring the pathophysiology of post-sepsis syndrome to identify therapeutic opportunities. EBioMedicine. 2020;61:103044.CrossRefPubMedPubMedCentral van der Slikke EC, An AY, Hancock REW, Bouma HR. Exploring the pathophysiology of post-sepsis syndrome to identify therapeutic opportunities. EBioMedicine. 2020;61:103044.CrossRefPubMedPubMedCentral
38.
go back to reference Barrett O, Abramovich E, Dreiher J, Novack V, Abu-Shakra M. Short- and long-term mortality due to sepsis in patients with rheumatoid arthritis. Rheumatol Int. 2017;37(6):1021–6.CrossRefPubMed Barrett O, Abramovich E, Dreiher J, Novack V, Abu-Shakra M. Short- and long-term mortality due to sepsis in patients with rheumatoid arthritis. Rheumatol Int. 2017;37(6):1021–6.CrossRefPubMed
39.
go back to reference Abramovich E, Barrett O, Dreiher J, Novack V, Abu-Shakra M. Incidence and variables associated with short and long-term mortality in patients with systemic lupus erythematosus and sepsis admitted in intensive care units. Lupus. 2018;27(12):1936–43.CrossRefPubMed Abramovich E, Barrett O, Dreiher J, Novack V, Abu-Shakra M. Incidence and variables associated with short and long-term mortality in patients with systemic lupus erythematosus and sepsis admitted in intensive care units. Lupus. 2018;27(12):1936–43.CrossRefPubMed
40.
go back to reference Dupuis C, Bouadma L, Ruckly S, Perozziello A, Van-Gysel D, Mageau A, Mourvillier B, de Montmollin E, Bailly S, Papin G, et al. Sepsis and septic shock in France: incidences, outcomes and costs of care. Ann Intensiv Care. 2020;10(1):145.CrossRef Dupuis C, Bouadma L, Ruckly S, Perozziello A, Van-Gysel D, Mageau A, Mourvillier B, de Montmollin E, Bailly S, Papin G, et al. Sepsis and septic shock in France: incidences, outcomes and costs of care. Ann Intensiv Care. 2020;10(1):145.CrossRef
41.
go back to reference Assan F, Bay P, Mathian A, Hekimian G, Bréchot N, Quentric P, Moyon Q, Schmidt M, Cohen-Aubart F, Haroche J, et al. In-ICU-acquired infections in flare-up systemic rheumatic disease patients receiving immunosuppressant. Clin Rheumatol. 2022;41(9):2845–54.CrossRefPubMed Assan F, Bay P, Mathian A, Hekimian G, Bréchot N, Quentric P, Moyon Q, Schmidt M, Cohen-Aubart F, Haroche J, et al. In-ICU-acquired infections in flare-up systemic rheumatic disease patients receiving immunosuppressant. Clin Rheumatol. 2022;41(9):2845–54.CrossRefPubMed
Metadata
Title
Prognostic impacts of repeated sepsis in intensive care unit on autoimmune disease patients: a retrospective cohort study
Authors
Jinming Yang
Jie Chen
Min Zhang
Qingsa Zhou
Bing Yan
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09072-y

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine